A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma
Status:
Recruiting
Trial end date:
2021-07-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nivolumab given intrathecally is effective
in the treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University